...
首页> 外文期刊>Phytotherapy research: PTR >Caffeic Acid Phenethyl Ester, a Component of Beehive Propolis, is a Novel Selective Estrogen Receptor Modulator
【24h】

Caffeic Acid Phenethyl Ester, a Component of Beehive Propolis, is a Novel Selective Estrogen Receptor Modulator

机译:咖啡酸苯乙基酯,蜂巢蜂胶的一种成分,是一种新型的选择性雌激素受体调节剂

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Caffeic acid phenethyl ester (CAPE) is an active ingredient of beehive propolis with a structure similar to phenolic acid. The estrogenic effects of propolis were previously demonstrated through the activation of an estrogen receptor. To identify the estrogenic properties of propolis, CAPE was evaluated using in vitro and in vivo methods. CAPE showed selective binding affinity to human estrogen receptor beta (hER beta) rather than hER alpha. CAPE also reduced ER alpha expression in MCF-7 and MDA 231 cells. In the yeast estrogen receptor transcription assay, CAPE produced the transcriptional activity of estrogen-responsive element with EC50 values of 3.72 x 10(-6) M. CAPE did not increase the growth of MCF-7 estrogen receptor-positive breast cancer cells in doses ranging from 10(-7) to 10(-5) M. In order to understand how CAPE acts in animals, CAPE was tested by a uterotrophic bioassay. Treatment with CAPE (100, 500 mg/kg) did not increase the uterine weight relative to 3 mu g/kg 17 beta-estradiol treatment. The results indicate that CAPE, which is a selective agonist to hER beta, but does not show any estrogenic effect on estrogen receptor-positive breast cancer cells and in immature rat uterine tissue, is a potential selective estrogen receptor modulator.
机译:咖啡酸苯乙酯(CAPE)是蜂巢蜂胶的活性成分,其结构类似于酚酸。蜂胶的雌激素作用先前已通过雌激素受体的激活得到证实。为了鉴定蜂胶的雌激素特性,使用体外和体内方法评估了CAPE。 CAPE对人雌激素受体β(hER beta)而非hER alpha具有选择性的结合亲和力。 CAPE还降低了MCF-7和MDA 231细胞中的ER alpha表达。在酵母雌激素受体转录试验中,CAPE产生的雌激素反应元件的转录活性为EC50值为3.72 x 10(-6)M。CAPE并未增加剂量的MCF-7雌激素受体阳性乳腺癌细胞的生长范围从10(-7)到10(-5)M。为了了解CAPE在动物中的作用,通过子宫营养生物测定法对CAPE进行了测试。相对于3μg/ kg的17β-雌二醇治疗,CAPE(100,500 mg / kg)的治疗并未增加子宫重量。结果表明,CAPE是hERβ的选择性激动剂,但对雌激素受体阳性的乳腺癌细胞和未成熟的大鼠子宫组织未显示任何雌激素作用,是一种潜在的选择性雌激素受体调节剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号